Click To Call

(678) 806-3851

Get In Touch / Schedule a Test

pharmacogenomic-image
By isolating and examining the regions of a patient’s DNA that code for the enzymes of interest, we can provide the following answers:

Q. How do enzymes interact with their targets, and how does the patient's genetic makeup affect these interactions?

A.

Enzymes modify drugs into their active and inactive metabolites. A person's genetic makeup may seriously affect how well certain enzymes perform.

Q. How well does the patient metabolize/utilize drugs, and what personal factors are being used to aid in drug selection?

A.

RESPONSE™ acts as a lifelong prescribing roadmap, steering the provider towards drugs that are metabolized efficiently and away from those that are not.

Q. Is there a system to identify when a patient is taking a medication that is poorly suited for them?

A.

RESPONSE™ acts as a safeguard, protecting both physician and patient from undesirable adverse drug reactions.

Q. How can a physician reduce drug-drug interactions when a patient is prescribed multiple medications?

A.

RESPONSE™ flags potentially dangerous interactions between drugs and often suggests suitable alternatives.

Response Offer

A lifelong prescribing roadmap that will steer the provider toward drugs that are metabolized efficiently and away from those that are not.

Response Offer

A safeguard, protecting both physician and patient from undesirable, adverse drug reactions and potentially dangerous drug-drug interactions.

Response Offer

In cases of potential adverse drug reactions or unfavorable drug-drug interactions, RESPONSE™ often suggests suitable alternatives.

Response Offer

Patients that experience less than optimal results from prescribed medications.

Response Offer

Patients with a personal or family history of adverse drug reactions in response to certain medications.

Response Offer

Patients taking multiple prescribed medications for multiple chronic conditions.

Response Offer

FDA studies estimate that 7% of hospitalized patients have a serious adverse drug reaction with a fatality rate of 0.32%.

Response Offer

There are more than 2,216,000 serious ADRs in hospitalized patients, causing over 106,000 deaths annually.

For more information, check out our test menu here:

© 2021 Serenity Laboratories, LLC. ALL RIGHTS RESERVED.
Design and Maintenance by Appeal Design